None

JRCT ID: jRCT1032230427

Registered date:31/10/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: depressive states
• Date of first enrollment: 08/12/2023
• Target sample size: 60
• Study type: Interventional
• Intervention(s): Regular online assessments once every 2 weeks, provision of mental health information on the website, and cognitive behavioral therapy intervention with emol once a week for a total of 8 sessions

Outcome(s)

• Primary Outcome: Change in PHQ-9 before and after intervention

Secondary Outcome

Correlation and relevance to the primary endpoints will be assessed in the following secondary endpoints
AIS,Analyzed data of voiceprint,Analyzed data of strength needed to write

Key inclusion & exclusion criteria

• Age minimum: >= 12age old
• Age maximum: < 18age old
• Gender: Both

Include criteria

(1) Age between 12 and 18 years old at the time of registration
(2) Patients on the waiting list at the Department of Child Psychiatry, Yokohama City University Hospital
(3) Patients with self-administered depression rating scale PHQ-9>=10 (moderate or higher depression)
(4) Patients who have a terminal environment that can run the mental self-care application "emol".
(5) Those who are able to use Zoom for online interviewing
(6) Those who have no difficulty in reading and writing Japanese at the upper elementary school level.
(7) Those who can agree not to use other mental self-care applications.
(8) Patients who can obtain written consent from their parents or guardians and the research subjects to participate in this study.

Exclude criteria

(1) Those with a high degree of urgency as judged by a child psychiatrist (those deemed appropriate to be seen within 8 weeks)
(2) Those who have reported suicide attempts within the past 2 weeks on the medical questionnaire.
(3) Those who have anorexia and have an imminent need for physical treatment.
(4) Patients who have been treated at other psychiatric institutions within the past month or who wish to be treated in the future.
(5) Those who continue to take psychotropic drugs prescribed by the above-mentioned medical institutions.
(6) Those who have difficulty in keeping a daily log due to an injury to their dominant hand.
(7) Other patients who are judged to be unsuitable for the program by the physician.

Related Information

• Primary Sponsor: Fujita Junichi
• Secondary Sponsor: Tomoyuki Miyazaki
• Source(s) of Monetary Support: FY2022-2031 Japan Science and Technology Agency (JST) "Co-creation Opportunity Formation Support Program (COI-NEXT),Zebra Holdings Corporation